Secondary hyperlipidaemia is an elevation of blood lipids caused by an underlying medical condition or medication rather than a primary genetic disorder. Recognising secondary causes is crucial in clinical practice because treating the root condition can normalise lipid levels and reduce cardiovascular risk. For example, uncontrolled diabetes mellitus often leads to secondary hyperlipidaemia, increasing the likelihood of atherosclerosis and related complications.